Nuclear notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer

Annals of Surgical Oncology

Volumn 21, Issue 8, 2014, Pages 2650-2658

  Ozawa, Tsuyoshi ^a   Kazama, Shinsuke ^a   Akiyoshi, Takashi ^b   Murono, Koji ^a   Yoneyama, Satomi ^a   Tanaka, Toshiaki ^a   Tanaka, Junichiro ^a   Kiyomatsu, Tomomichi ^a   Kawai, Kazushige ^a   Nozawa, Hiroaki ^a   Kanazawa, Takamitsu ^a   Yamaguchi, Hironori ^a   Ishihara, Soichiro ^a   Sunami, Eiji ^a   Kitayama, Joji ^a   Morikawa, Teppei ^a   Fukayama, Masashi ^a   Watanabe, Toshiaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH1 RECEPTOR; NOTCH3 RECEPTOR; PROTEIN MLH1; PROTEIN MSH2; TUMOR MARKER; NOTCH RECEPTOR; NOTCH1 PROTEIN, HUMAN; NOTCH3 PROTEIN, HUMAN;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CLINICAL FEATURE; COLORECTAL CARCINOMA; CORRELATION ANALYSIS; CYTOPLASM; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; NUCLEOTIDE SEQUENCE; PROTEIN LOCALIZATION; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION; TUMOR RECURRENCE; ADENOCARCINOMA; COLORECTAL TUMOR; ENZYME IMMUNOASSAY; FOLLOW UP; METABOLISM; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR INVASION;

ADENOCARCINOMA; AGED; CELL NUCLEUS; COLORECTAL NEOPLASMS; CYTOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, NOTCH1; RECEPTORS, NOTCH; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84905087784     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3659-9     Document Type: Article

References (26)

1. Artavanis-Tsakonas S, Muskavitch MA. Notch: the past, the present, and the future. Curr Top Dev Biol. 2010;92:1-29.
2. Ellisen LW, Bird J, West DC, et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 1991;66:649-61. (Pubitemid 121001701)
3. Liu J, Fan H, Ma Y, et al. Notch1 is a 5-fluorouracil resistant and poor survival marker in human esophagus squamous cell carcinomas. PLoS One. 2013;8:e56141.
4. Mullendore ME, Koorstra JB, Li YM, et al. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clin Cancer Res. 2009;15:2291-301.
5. Reedijk M, Odorcic S, Chang L, et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005;65:8530-7. (Pubitemid 41330622)
6. Park JT, Chen X, Tropè CG, et al. Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin. Am J Pathol. 2010;177:1087-94.
7. Miyamoto S, Rosenberg DW. Role of Notch signaling in colon homeostasis and carcinogenesis. Cancer Sci. 2011;102:1938-42.
8. Bellavia D, Checquolo S, Campese AF, et al. Notch3: from subtle structural differences to functional diversity. Oncogene. 2008;27:5092-8.
9. Chu D, Zhang Z, Zhou Y, et al. Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer. Ann Oncol. 2011;22:2440-7.
10. Parr C, Watkins G, Jiang WG. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med. 2004;14:779-86.
11. Serafin V, Persano L, Moserle L, et al. Notch3 signalling promotes tumour growth in colorectal cancer. J Pathol. 2011;224:448-60.
12. Morikawa T, Kuchiba A, Qian ZR, et al. Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer. Ann Surg Oncol. 2012;19:1944-53.
13. Liao X, Lochhead P, Nishihara R, et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med. 2012;367:1596-606.
14. Rhodes A, Jasani B, Barnes DM, et al. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol. 2000;53:125-30. (Pubitemid 30075056)
15. Smith JJ, Deane NG, Wu F, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 2010;138:958-68.
16. Jorissen RN, Gibbs P, Christie M, et al. Metastasis-associated gene expression changes predict poor outcomes in patients with dukes stage B and C colorectal cancer. Clin Cancer Res. 2009;15:7642-51.
17. Mann CD, Bastianpillai C, Neal CP, et al. Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma. PLoS One. 2012;7:e51119.
18. Yeasmin S, Nakayama K, Rahman MT, et al. Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes. Gynecol Oncol. 2010;117:409-16.
19. Pierfelice TJ, Schreck KC, Dang L, et al. Notch3 activation promotes invasive glioma formation in a tissue site-specific manner. Cancer Res. 2011;71:1115-25.
20. Doucas H, Mann CD, Sutton CD, et al. Expression of nuclear Notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt. J Surg Oncol. 2008;97:63-8.
21. Hornberger J, Lyman GH, Chien R, Meropol NJ. A multigene prognostic assay for selection of adjuvant chemotherapy in patients with T3, stage II colon cancer: impact on qualityadjusted life expectancy and costs. Value Health. 2012;15:1014-21.
22. Zhang Y, Li B, Ji ZZ, Zheng PS. Notch1 regulates the growth of human colon cancers. Cancer. 2010;116:5207-18.
23. Chu D, Li Y, Wang W, et al. High level of Notch1 protein is associated with poor overall survival in colorectal cancer. Ann Surg Oncol. 2010;17:1337-42.
24. Chu D, Zhou Y, Zhang Z, et al. Notch1 expression, which is related to p65 Status, is an independent predictor of prognosis in colorectal cancer. Clin Cancer Res. 2011;17:5686-94.
25. Hofmann JJ, Iruela-Arispe ML. Notch signaling in blood vessels: who is talking to whom about what? Circ Res. 2007;100:1556-68. (Pubitemid 46897259)
26. Sonoshita M, Aoki M, Fuwa H, et al. Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. Cancer Cell. 2011;19:125-37.